STELARAÂ ustekinumab Data Demonstrate Longterm Efficacy and Safety Results in Adults With Moderately to Severely Active Ulcerative Colitis in Phase 3 Extension Trial

Twoyear UNIFI data presented for the first time as a late breaking oral presentation at United European Gastroenterology Week UEGW congressThe Janssen Pharmaceutical Companies of Johnson & Johnson today announced new twoyear data from the longterm ...